Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Requirement of Rac1 in the development of cardiac hypertrophy.

Authors: Satoh, M  Ogita, H  Takeshita, K  Mukai, Y  Kwiatkowski, DJ  Liao, JK 
Citation: Satoh M, etal., Proc Natl Acad Sci U S A. 2006 May 9;103(19):7432-7. Epub 2006 May 1.
Pubmed: (View Article at PubMed) PMID:16651530
DOI: Full-text: DOI:10.1073/pnas.0510444103

The development of cardiac hypertrophy is mediated, in part, by increase in NADPH oxidase activity and myocardial oxidative stress. The Rho GTPase, Rac, regulates NADPH oxidase activity through interaction with gp91(phox) and p67(phox) (in which "phox" is phagocyte oxidase). However, it is not known which Rac isoform mediates this effect in the heart. Here we show that Rac1 is critical for generating oxidative stress and producing cardiac hypertrophy in the adult heart. The Rac1 gene was temporally and specifically deleted in adult mouse cardiomyocytes (c-Rac1(-/-)). Compared with wild-type or Rac1 heterozygous mice, the hearts of c-Rac1(-/-) mice showed decreased gp91(phox) and p67(phox) interaction, NADPH oxidase activity, and myocardial oxidative stress in response to angiotensin II (400 ng/kg per day for 2 weeks) stimulation. This result correlated with decreased myocardial hypertrophy. These results indicate that Rac1 is critical for the hypertrophic response in the heart and suggest that therapies which target myocardial Rac1 may be beneficial in the treatment of cardiac hypertrophy.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 1581294
Created: 2006-09-25
Species: All species
Last Modified: 2006-09-25
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.